Daily use keeps relatively stable plasma levels and provides consistent receptor start
All authors approved the final draft
Medication can help manage these systems, but long-term success is usually strongest when pharmacological treatment is combined with structured lifestyle support.
Daily Use: Twice daily (morning & night) on clean, dry skin
Therefore, the combined use of GLP-1 RAs with therapies targeting intrahepatic pathways, such as thyroid hormone receptor (THR-) agonists, fibroblast growth factor-21 (FGF21) analogues, and peroxisome proliferator-activated receptor (PPAR) agonists, presents a promising approach for MASH treatment
An injection needle is used after the medication is drawn when a separate injection needle is part of the prescribed routine